The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry.

Publication Year: 2023

DOI:
10.1007/s10120-023-01444-8

PMCID:
PMC10896809

PMID:
38146035

Journal Information

Full Title: Gastric Cancer

Abbreviation: Gastric Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestTsuyoshi Takahashi received Honoraria from Pfizer, Bayer Yakuhin, Ltd, Taiho Pharmaceutical, Nippon Kayaku and Sawai Pharmaceutical Co., Ltd. outside the submitted work, and received the payment from Taiho Pharmaceutical. Toshirou Nishida reports Honoraria from Pfizer, Taiho Pharmaceutical and Eisai Co. outside the submitted work. Other authors declare that they have no conflict of interest. Ethics approvalThe Human Ethics Review Committee of the Osaka University Graduate School of Medicine approved the protocol for this retrospective study (Approval No. 18424-2). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consentInformed consent to be included in the study, or the equivalent, was obtained from all patients. Consent for publicationConsent for publication was obtained from all individuals whose data appears in the paper. Conflict of interest Tsuyoshi Takahashi received Honoraria from Pfizer, Bayer Yakuhin, Ltd, Taiho Pharmaceutical, Nippon Kayaku and Sawai Pharmaceutical Co., Ltd. outside the submitted work, and received the payment from Taiho Pharmaceutical. Toshirou Nishida reports Honoraria from Pfizer, Taiho Pharmaceutical and Eisai Co. outside the submitted work. Other authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding Open access funding provided by Osaka University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025